Back to search
Psychedelic Effects in Healthy Volunteers
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Psychedelic Effects in Healthy Volunteers trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Psychedelic Effects in Healthy Volunteers trials you may qualify forParticipation in this study lasts approximately two weeks and includes three on-site study visits: a screening visit (approximately 2 hours), a study drug admin…
The aim of this double-blind, placebo-controlled, within-subjects study is to determine whether other psychoactive substances can produce experiences akin to th…
The purpose of this study is to assess the effects of 5-HT1A receptor blockade on the acute subjective effects of psilocybin, as measured through subjective sur…
The purpose of this study is to determine the importance of the acute subjective experience induced by psilocybin (the primary component of "magic mushrooms") i…
The main objective of this study is to determine whether administration of ketanserin (40 mg), olanzapine (10 mg), and lorazepam (2 mg) after administration of…